RYALX
Price
$137.61
Change
-$1.87 (-1.34%)
Updated
Mar 5 closing price
Net Assets
16.74M
RYVTX
Price
$134.11
Change
-$3.65 (-2.65%)
Updated
Mar 5 closing price
Net Assets
10.74M
Ad is loading...

RYALX vs RYVTX

Header iconRYALX vs RYVTX Comparison
Open Charts RYALX vs RYVTXBanner chart's image
Rydex Inverse NASDAQ-100® Strategy H
Price$137.61
Change-$1.87 (-1.34%)
VolumeN/A
Net Assets16.74M
Rydex Inverse NASDAQ-100® 2x Strategy A
Price$134.11
Change-$3.65 (-2.65%)
VolumeN/A
Net Assets10.74M
RYALX vs RYVTX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RYALX vs. RYVTX commentary
Mar 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYALX is a Hold and RYVTX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
RYALX has more cash in the bank: 16.7M vs. RYVTX (10.7M). RYALX (5.46) and RYVTX (5.31) have matching dividends . RYALX was incepted earlier than RYVTX: RYALX (10 years) vs RYVTX (21 years). RYALX (2500) and RYVTX (2500) have matching initial minimum investment requirements. RYALX annual gain was more profitable for investors over the last year : -12.90 vs. RYVTX (-25.44). RYALX return over 5 years is better than : -68.20 vs. RYVTX (-92.58).
RYALXRYVTXRYALX / RYVTX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years21 years-
Gain YTD3.7806.54358%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/A1000-
Net Assets16.7M10.7M156%
Annual Yield % from dividends5.465.31103%
Returns for 1 year-12.90-25.4451%
Returns for 3 years-36.73-65.6456%
Returns for 5 years-68.20-92.5874%
Returns for 10 years-85.96-98.7787%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HDB60.320.62
+1.04%
HDFC Bank Limited
ARCB74.900.73
+0.98%
ArcBest Corp
OGE44.65-0.47
-1.04%
OGE Energy Corp
TRVI4.39-0.05
-1.13%
Trevi Therapeutics
IOBT0.90-0.01
-1.56%
IO Biotech